Public sector services for the prevention of mother-to-child transmission of HIV infection: a micro-costing survey in Namibia and Rwanda
- 26 March 2013
- journal article
- research article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 91 (6), 407-415
- https://doi.org/10.2471/BLT.12.113639
Abstract
Objective To assess the costs associated with the provision of services for the prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus in two African countries. Methods In 2009, the costs to health-care providers of providing comprehensive PMTCT services were assessed in 20 public health facilities in Namibia and Rwanda. Information on prices and on the total amount of each service provided was collected at the national level. The costs of maternal testing and counselling, male partner testing, CD4+T-lymphocyte (CD4+cell) counts, antiretroviral prophylaxis and treatment, community-based activities, contraception for 2 years postpartum and early infant diagnosis were estimated in United States dollars (US$). Findings The estimated costs to the providers of PMTCT, for each mother-infant pair, were US$ 202.75-1029.55 in Namibia and US$ 94.14-342.35 in Rwanda. These costs varied with the drug regimen employed. At 2009 coverage levels, the maximal estimates of the national costs of PMTCT were US$ 3.15 million in Namibia and US$ 7.04 million in Rwanda (or <US$ 0.75 per capita in both countries). Adult testing and counselling accounted for the highest proportions of the national costs (37% and 74% in Namibia and Rwanda, respectively), followed by management and supervision. Treatment and prophylaxis accounted for less than 20% of the costs of PMTCT in both study countries. Conclusion The costs involved in the PMTCT of HIV varied widely between study countries and in accordance with the protocols used. However, since per-capita costs were relatively low, the scaling up of PMTCT services in Namibia and Rwanda should be possible.Keywords
This publication has 15 references indexed in Scilit:
- The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation ModelPLOS ONE, 2012
- Nevirapine for the Prevention of Mother-to-Child Transmission of HIV: A Nation-Wide Coverage Survey in Côte d'IvoireJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited settingAIDS, 2011
- The Global Fund: a bleak future aheadThe Lancet, 2010
- HIV Spending as a Share of Total Health Expenditure: An Analysis of Regional Variation in a Multi-Country StudyPLOS ONE, 2010
- Coverage of Nevirapine-Based Services to Prevent Mother-to-Child HIV Transmission in 4 African CountriesPublished by American Medical Association (AMA) ,2010
- Countdown to 2015 decade report (2000–10): taking stock of maternal, newborn, and child survivalThe Lancet, 2010
- Patient retention in antiretroviral therapy programs up to three years on treatment in sub‐Saharan Africa, 2007–2009: systematic reviewTropical Medicine & International Health, 2010
- Flat-line funding for PEPFAR: a recipe for chaosThe Lancet, 2009
- Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countriesSexually Transmitted Infections, 2008